Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,

Slides:



Advertisements
Similar presentations
Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
Advertisements

Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Safety and Extrapolation Steven Hirschfeld, MD PhD Office of Cellular, Tissue and Gene Therapy Center for Biologics Evaluation and Research FDA.
CLINICAL EVALUATION OF HERBAL REMEDIES AND MEDICINAL PLANTS Some issues GCP for new drug clinical trials in India R.Raveendran Chief Editor Indian Journal.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Clinical Trials Medical Interventions
Regulatory and Industry Requirements for Botanical Drug Products Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University.
Special Topics in IND Regulation
Stefan Franzén Introduction to clinical trials.
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
Technical Briefing Seminar, WHO Headquarters, September WHO Traditional Medicine Strategy Dr Samvel Azatyan Traditional Medicine (TRM) Department.
Personal and Consumer Health 1. Objectives 1.Demonstrate the ability to access and describe health information, health products, and health services in.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Clinical Pharmacy Basma Y. Kentab MSc..
Complementary / alternative medicine. What is complementary and alternative medicine (CAM)?   It is a group of diverse medical and health care systems,
Stages of drug development
WHO Traditional Medicine Strategy and Guidelines Dr Arvind Mathur MD, DHA, DNB Cluster Coordinator Family & Community Health WHO-India World Health Organisation.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
19/08/2007 KLE University, Belgaum, India1 REGULATORY GUIDELINES FOR PRECLINICAL AND CLINICAL VALIDATION OF TRADITIONAL MEDICINES Dr. Basavaraj K. Nanjwade.
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Data protection and extension of patent rights TRIPS requirements & TRIPS-plus provisions Carlos Correa.
Pharmacovigilance obligations of the Pharmaceutical companies in India
Jasper Ogwal-Okeng Gulu University Research Workshop 3 rd -6 th March 08.
Stefan Franzén Introduction to clinical trials.
Jennifer Orwa, PhD, OGW Chief Research Officer, Kenya Medical Research Institute, Center for Traditional Medicine and Drug Research Presentation at the.
Healthcare Philosophies. What are they? As with many things in life there are a few different approaches to medical knowledge. Think of it like different.
Biomedical Research.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 1 A Brief History.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
ACCESS TO MEDICINES - POLICY AND ISSUES
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Developing medicines for the future and why it is challenging Angela Milne.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
History of Pediatric Labeling
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
Medical Knowledge Systems. What are they? As with many things in life there are a few different approaches to medical knowledge. Think of it like different.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Medical Research and Clinical Trials Rels 300 / Nurs October 2015.
European Patients’ Academy on Therapeutic Innovation Ethical and practical challenges of organising clinical trials in small populations.
Indian Clinical Trials- The Unaddressed Challenges of Regulatory Amendments Dr. N. Srinivas Principal Malla Reddy Institute of Pharmaceutical Sciences.
Complementary and Alternative Medicine
Clinical Trials - PHASE II. Introduction  Important part of drug discovery process  Why important??  Therapeutic exploratory trial  First time in.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
GCP Guidelines for ASU drugs- Issues & Solutions
Course: Pharmacognosy-I Course Instructor: Nishat Jahan.
CHAPTER 8 Global Use of Complementary and Alternative Medicine (CAM) and Treatments.
Audit on herbal study protocols reviewed by an Ethics Review Committee of a Western Medical Institution Wanigatunge CA, Warnacula G, Prathapan S Ethics.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Drug Development Process Stages involved in Regulating Drugs
CLINICAL TRIALS.
Clinical Trials — A Closer Look
REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.
Within Trial Decisions: Unblinding and Termination
Clinical Trials Medical Interventions
Introduction to Clinical Pharmacy
Complementary and Alternative Medicine
Bozeman Health Clinical Research
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Clinical Trials.
By Hatim Jaber MD MPH JBCM PhD
Speeding access to therapies
Complementary and Alternative Medicine
Prescription-only vs. over-the-counter medicines
Evidence-Based Public Health
VICH GL 54, Studies to evaluate the safety of residues of veterinary drugs in human food: General approach to establish an Acute Reference Dose (ARfD)
Presentation transcript:

Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences, New Delhi

Introduction Use of traditional medicines (TM) remains widespread in developing countries like India Use of complementary and alternative medicine (CAM) is increasing rapidly in developed countries For the use of large animals, permission to be obtained from Chennai office.

What includes Traditional Medicines? Diversity of health practices, approaches, knowledge, and beliefs incorporating plant, animal, and/or mineral-based medicines; spiritual therapies; manual techniques; and exercises, applied singly or in combination maintain well-being, as well as to treat, diagnose, or prevent illness …..WHO

Potential Risks Direct risks of adverse effects and drug interactions Indirect risk that an traditional remedies without demonstrated efficacy may compromise, delay or replace an effective form of conventional treatment.

Hazardous in specific patients under special circumstances or when combined with conventional drugs. Risks….

The substance is being clinically evaluated for same indication for which it is being used or as has been described in the texts. b. An extract of a plant or a compound isolated from the plant has to be clinically evaluated for a therapeutic effect not originally described in the texts of traditional systems- new chemical entity (NCE) Never been in use before and has not ever been mentioned in ancient literature. Categories of Herbal Drugs

Methodological quality is variable Quality of the trial drug has to be tested for batch-to-batch uniformity of the active constituents Source, processing, and final composition of the herbal product Herbal trials generally use placebo and not an active comparator Concerns about Clinical Study Designs

Study should be adequately powered. Combined use of an herbal medication and a conventional drug considered in clinical trials Adequate doses of both herbal drug and active comparator to be used Concerns about Clinical Study Designs….

If Design of the trial is appropriate to provide the expected outcomes for the traditional medicine. Whether the methodology limits the treatment procedure of traditional medicine. Benchmarks Of A Clinical Trial Using Herbal/Traditional Medicines

In order to avoid the loss or alteration of the efficacy of the substance, validated methods needed while adapting modern method to formulate and dispense the medicaments. Benchmarks Of A Clinical Trial Using Herbal/Traditional Medicines……..

Challenges Regulatory Status Assessment of safety Efficacy Quality Control

Regulatory Requirements For The Conduct Of Clinical Trials on Herbal Medicines Traditional medicines are governed by the Drugs and Cosmetics Act of 1940 and the Drugs and Cosmetics Rules of In 1959, the Government of India amended the Drugs and Cosmetics Act to include drugs which are derived from traditional Indian medicine

Regulatory Requirements….. In 1993, the guidelines for the safety and efficacy of herbal medicines developed by an expert committee No new herbal medicines other than those authorized by the licensing authorities be allowed to be manufactured or marketed, except for those mentioned in ancient scriptures

The procedures laid down by the office of the DCGI for allopathic drugs should be followed for all traditional and herbal products to enter into clinical trials for any therapeutic condition. Regulatory Requirements…..

Co-investigators/collaborators of the expert group are from the associations of physicians from the concerned system for designing and evaluating the Study. Regulatory Requirements…..

Phases of Clinical Trials Phase I studies may not be necessary Need for testing its toxicity in animals has been considerably reduced. Toxicity study may not be needed for phase II trial unless reports suggesting toxicity/herbal preparation is to be used for more than 3 months

Larger multicentric phase III trial is subsequently planned based on results of phase II study. These trials have also got to be approved by the appropriate scientific and ethical committees of the concerned Institutes Phases of Clinical Trials…

Challenges which need to be addressed Quality control of herbal medicines is complicated and difficult Relevant appropriate requirements should be established for the assessment of safety and efficacy for different categorized herbal medicines to reduce cost and expenditure Integration of traditional medicine into national health systems